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Abstract

Purpose: Optimal HIV pre-exposure prophylaxis (PrEP) scale-up in the United States requires prescribing by
primary care providers (PCPs). We assessed barriers to patients obtaining PrEP from their PCPs.
Methods: Patients seeking PrEP at an Infectious Diseases (ID) Clinic in St. Louis, Missouri from 2014 to 2016
were asked about demographics, sexual behaviors, whether PrEP was initially sought from their PCP, and barriers to obtaining PrEP from their PCP. Multivariable logistic regression was performed to identify predictors for
having asked a PCP for PrEP.
Results: Among 102 patients, the median age was 29 years, 58% were white, and 88% were men who have sex
with men. Most (65%) had a PCP and, of these, 48% had asked their PCP for PrEP, but were not prescribed it.
About half (52%) reported that their PCPs perceived prescribing PrEP as specialty care. Many (39%) indicated
that they felt uncomfortable discussing their sexual behaviors with their PCP. Patients with an HIV-positive sex
partner in the last 3 months were less likely to ask for PrEP from their PCPs than others (Adjusted Odds Ratio:
0.07; 95% CI: 0.01–0.53). Eighty-three percent of patients were referred to a new PCP with whom they could feel
more comfortable discussing PrEP.
Conclusions: During initial PrEP implementation, ID specialists can play an important role in providing education
and linking PrEP patients to PCPs. However, PCPs may need additional training about PrEP and how to provide
culturally sensitive sexual healthcare, if widespread scale-up is to be effective in decreasing HIV incidence.
Keywords: healthcare

providers, HIV prevention, implementation, pre-exposure prophylaxis (PrEP), primary care

Introduction

I

n 2014, over 40,000 human immunodeficiency virus
(HIV) infections were diagnosed in the United States.1
Antiretroviral pre-exposure prophylaxis (PrEP) is an HIV
prevention approach that has the potential to reduce the number of new HIV infections significantly. Currently available,
FDA-approved PrEP is a fixed dose combination of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF), which
is taken once daily by at-risk HIV-negative individuals to
prevent HIV acquisition. Major studies have demonstrated
the efficacy of PrEP in preventing HIV among men who

have sex with men (MSM), heterosexuals, and injection
drug users.2–6 The Centers for Disease Control and Prevention (CDC) estimates that national PrEP implementation
could potentially reduce HIV incidence by 70% by 2020.7
Expanding PrEP use alone among key populations has the
potential to prevent an estimated 50,000 new infections.8
The CDC and the International Antiviral Society-USA
Panel recommend integrating PrEP into routine HIV prevention services offered by primary care providers (PCPs).9,10
As PrEP is implemented in nonresearch settings, noninfectious diseases (ID) specialists will play a critical role
in scale-up. The number of ID specialists is declining.11–13

1

Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Division of Infectious Diseases, Department of Medicine, Brown University, Providence, Rhode Island.
Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
4
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
5
The Fenway Institute, Fenway Health, Boston, Massachusetts.
6
Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island.
7
The Rhode Island Public Health Institute, Providence, Rhode Island.
8
Division of Infectious Diseases, Department of Medicine, University of Mississippi, Jackson, Mississippi.
2
3

250

Downloaded by Washington Univ from www.liebertpub.com at 06/20/18. For personal use only.

MISSED PrEP OPPORTUNITY BY PCPS IN ST. LOUIS

251

Moreover, encouraging PCPs to prescribe PrEP will integrate
sexual health services with primary care, which is more holistic
for otherwise healthy patients.14 However, few (7%) PCPs
have prescribed PrEP despite moderate levels of awareness
of (66%) and high willingness to prescribe PrEP (91%).15 Reasons for a lack of provider prescribing include a lack of awareness, comfort with prescribing antiretrovirals, and organization
administrative support, as well as concerns regarding risk compensation.16–28 The goals of this study were to explore whether
patients seeking PrEP at an ID specialty clinic were engaged in
primary care, if they had asked their PCPs about PrEP before
seeking specialty care, and to identify the reasons why patients
did not ask their PCPs for PrEP and why PCPs had declined to
prescribe PrEP.

of mental illness (e.g., anxiety, depression, schizophrenia,
attention-deficit/hyperactivity disorder, or bipolar disorder).
MSM was defined as a male patient who reported a history
of having sex with men on the self-administered survey.
The association between independent variables and the outcomes was initially assessed using chi-square and Fisher’s
exact tests. Statistical tests were two-sided and the significance level was set at 0.05. Multivariable logistic regression
was performed for all outcomes. Variables included in the regression analysis included those that were significant in

Methods

Demographics
Median age (years) (IQR)
29 (25–34)
Age (years)
18–24
23
25–34
55
>34
24
Gender
Male
93
Female
8
Other
1
Race
White
59
Black
32
Latino/Hispanic
3
Asian
3
Multiracial
5
Highest level of education
Less than college
35
College graduate
36
Postgraduate
30
Annual income ($)
£12,000
24
12,001–24,000
20
24,001–36,000
22
>36,000
33
Has insurance coverage
None
5
Publica
8
Private
88
Other
1
Sexual risk
Median sexual partners in the
2 (1–5)
last 3 months (IQR)
Men who have sex with men (MSM)
90
Having an HIV-positive sex partner
43
in the last 3 months
Laboratory-confirmed STI
14
on initial visitb
MSM who had condomless anal sex
63
in the past 3 months (n = 90)
Has ever used intravenous drugs
2
Self-reported history of mental illness
33

We conducted a cross-sectional survey among new patients
who presented for PrEP care at the Washington University in
St. Louis (WUSTL) ID specialty clinic between June 2014 and
February 2016. Referrals to the clinic were from friends, word
of mouth, community providers, community-based organizations, and self-referral. The self-administered survey, performed during the first appointment at the WUSTL ID
specialty clinic, included questions about demographics, sexual behaviors, and whether patients had a PCP for PrEP. Survey answers were verified by the ID physician. A PCP was
defined as a ‘‘primary care provider’’ whom they visited
within the 12 months before visiting the WUSTL ID clinic.
Patients with a PCP were asked why they did not seek or obtain PrEP services from their PCP. We reviewed medical records to see if patients, who were referred to a PCP, had
obtained a PCP within 12 months of the patient’s initial clinic
visit date. We obtained the reasons for not obtaining a new
PCP after referral from clinic charts and patient verification.
Study inclusion criteria were 18 years or older, presented at
the WUSTL ID specialty clinic for care, and were able to provide written informed consent. The study was approved by the
WUSTL Institutional Review Board.
We also reviewed available results of sexually transmitted
infections (STI) testing, which was performed during routine
PrEP care in accordance with the CDC PrEP Clinical Practice Guidelines.10 STIs tested for were syphilis with rapid
plasma reagin (RPR) and Neisseria gonorrhea (NG) and
Chlamydia trachomatis (CT) with nucleic acid amplification
testing at any one site, including pharyngeal, urine, or rectal
(Gen-Probe TIGRIS APTIMA Combo 2 Assay, Hologic,
Inc., San Diego, CA for NG/CT and Alere Inc., Waltham,
MA for RPR). RPR tests were confirmed with fluorescent
treponemal antibody absorption testing (ZEUS Scientific,
Branchburg, NJ).
Data were analyzed by multivariable logistic regression to
determine the association of demographic and behavioral
variables with patients who: (1) Had a PCP; and (2) Asked
their PCP for PrEP; and (3) Felt uncomfortable discussing
sexual behaviors with their PCP. Demographic variables
were age, gender, race, education, annual income, and insurance. Behavioral variables were total sexual partners and had
anal or vaginal sex with a known HIV-positive partner in the
last 3 months, MSM, laboratory-confirmed STI test on initial
visit, MSM who had condomless anal sex in the past 3 months,
having ever used intravenous drugs, and self-reported history

Table 1. Patient Characteristics (N = 102)
n

%

22.5
53.9
23.5
91.1
7.8
1.0
57.8
31.4
2.9
2.9
4.9
34.7
35.6
29.7
24.2
20.2
22.2
33.3
4.9
7.8
86.3
1.0

88.2
42.2
14.0
70.0
2.0
32.4

Certain numbers may not sum to the total sample due to missing data.
a
Public insurance includes Medicaid, Medicare, and a city insurance program called Gateway to Better Health.
b
Laboratory-confirmed STI includes any one positive test result
for syphilis, Neisseria gonorrhea (pharyngeal, urine, or rectal), or
Chlamydia trachomatis (pharyngeal, urine, or rectal).
IQR, interquartile range; STI, sexually transmitted infection.
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FIG. 1 Forty-eight percent (32/
66) of PrEP seekers with a PCP
were not prescribed PrEP and potentially missed the opportunity to
obtain PrEP within a primary care
setting before presenting to an academic infectious diseases clinic.
PCP, primary care provider; PrEP,
pre-exposure prophylaxis.

bivariate analysis and also the demographic variables of age,
race, education, and annual income. In addition, we adjusted
for gender for the outcome of having had a PCP. For each independent variable, an odds ratio (OR), 95% confidence interval (95% CI), and P value were calculated. Analysis
was performed in SPSS Statistics for Windows Version 23
(IBM Corporation, Armonk, NY).
Reasons for not being prescribed or not asking for PrEP
were obtained by using open-ended survey questions. These
answers were categorized by two independent study team
members and the frequencies for each category were reported.
Reasons for not obtaining a new PCP after referral were categorized and the frequencies reported. Each patient could
have multiple reasons for each question.
Results

A total of 108 new patients presented at the WUSTL ID specialty clinic for PrEP care during the study period; 102 were enrolled in the study and six declined to participate in the study.
Among the 102 patients, the median age was 29 years (Interquartile Range [IQR] 25–34); 91% were male, 58% white,
31% Black, 3% Latino/Hispanic, 65% graduated college, median annual income was $27,000 (IQR $13,350–$46,000), and
95% had any insurance coverage. Most (88%) patients were
MSM, 42% had an HIV-positive sex partner in the last 3
months, 14% had a laboratory-confirmed STI, and 2% had
ever used intravenous drugs. Among MSM, 70% reported condomless anal sex in the past 3 months. Notably, 32% of the patients self-reported a history of mental illness (Table 1).
Thirty-five percent (36/102) of patients did not have a PCP
when they sought PrEP at the clinic (Fig. 1). Compared with
those with a PCP, those without a PCP were more often nonwhite: 69% (25/36) versus 27% (18/66, P < 0.001). Of those
who had a PCP, 48% reported asking their PCP for PrEP, but
were not prescribed it (Fig. 1). Age, race, education, and selfreported history of mental illness were significantly associated
with having had a PCP in bivariate analysis. Multivariable regression analysis for having a PCP is demonstrated in Table 2.
When adjusting for age, gender, education, annual income,
and self-reported history of mental illness, race remained a
significant predictor for having a PCP; non-whites were less
likely to have a PCP than whites (OR: 0.32; 95% CI: 0.10–
0.96, P = 0.04).
Compared with those who asked for PrEP from their PCP,
those who did not more often had an HIV-positive sex
partner (65%, 22/34 vs. 21%, 6/28; P < 0.001) and felt un-

comfortable discussing their sexual behaviors with their
PCP (55%, 18/33 vs. 23%, 7/31; P = 0.01). Age, race, annual
income, self-reported history of mental illness, and having
had an HIV-positive sex partner were significantly associated
with having asked a PCP for PrEP in bivariate analysis.
Table 3 displays the multivariable regression analysis results
for patients having asked their PCP for PrEP when adjusting
for age, race, education, annual income, self-reported history
of mental illness, and having an HIV-positive sex partner.
Self-reported history of mental illness (OR: 18.19; 95% CI:

Table 2. Multivariable Regression Analysis
for Having a Primary Care Provider Among
102 Patients Who Sought HIV Pre-Exposure
Prophylaxis Care at an Academic Infectious
Diseases Clinic, June 2014–February 2016
Variable
Age (years)
18–24
25–34
>34
Gender
Male
Female
Race
White
Non-white
Education
Less than college
College graduate
Postgraduate
Annual income ($)
£12,000
12,001–24,000
24,001–36,000
>36,000
Self-reported history
of mental illness
No
Yes

OR

95% CI

aORa

1.0
2.07
4.15*

1.0
0.77–5.56 1.05
1.15–14.92 1.42

1.0
1.73

0.33–9.05

1.0
0.17*** 0.07–0.43

1.0
6.99

95% CI

0.27–4.05
0.25–8.02
0.95–51.16

1.0
0.32* 0.10–0.96

1.0
4.00**
4.38**

1.0
1.46–10.97 3.12
1.49–12.89 2.44

0.88–11.15
0.59–10.07

1.0
0.69
2.26
3.14

1.0
0.21–2.28 0.77
0.66–7.76 1.90
0.99–10.01 1.72

0.18–3.24
0.40–8.99
0.36–8.30

1.0
3.46*

1.27–9.45

1.0
2.78

0.78–9.93

a
Adjusted for age, gender, race, education, annual income, and
self-reported history of mental illness.
*P £ 0.05.
**P £ 0.01.
***P £ 0.001.
OR, odds ratio; aOR, adjusted odds ratio; 95% CI, 95% confidence interval.
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Variable

OR

95% CI

aORa

95% CI

Age (years)
18–24
1.0
1.0
25–34
0.47
0.11–2.06 2.30
0.21–25.75
>34
0.10** 0.02–0.56 0.46
0.03–6.70
Race
White
1.0
1.0
Non-white
0.30*
0.09–0.97 0.25
0.04–1.55
Education
Less than college 1.0
1.0
College graduate 1.88
0.52–6.76 1.46
0.18–11.92
Postgraduate
1.38
0.37–5.14 1.18
0.11–13.02
Annual income ($)
£12,000
1.0
1.0
12,001–24,000
0.56
0.10–3.25 1.03
0.03–31.96
24,001–36,000
0.74
0.16–3.50 1.00
0.08–13.53
>36,000
0.20*
0.05–0.84 0.05
0.002–1.10
Self-reported history of mental illness
No
1.0
1.0
Yes
8.91*** 2.84–27.98 18.19** 2.73–121.39
Having an HIV-positive sex partner in the last 3 months
No
1.0
1.0
Yes
0.13*** 0.04–0.39 0.07** 0.01–0.53
a
Adjusted for age, race, education, annual income, self-reported
history of mental illness, and having an HIV-positive sex partner.
*P £ 0.05.
**P £ 0.01.
***P £ 0.001.

2.73–121.39, P = 0.003) was a significant positive predictor
of having asked their PCP for PrEP; however, having an
HIV-positive sex partner in the last 3 months (OR: 0.07;
95% CI: 0.01–0.53, P = 0.01) was a significant negative predictor for having asked for PrEP.
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Overall, 39% of those who reported having a PCP indicated that they had felt uncomfortable speaking to their
PCP about their sexual behavior. However, of those who
felt comfortable, 62% asked their PCP for PrEP, but were
not provided with a prescription (Fig. 2). Having had an
HIV-positive sex partner was significantly associated with
patients having felt uncomfortable discussing their sexual
behavior with their PCP in bivariate analysis. Table 4 displays the multivariable regression analysis results for patients who felt uncomfortable discussing their sexual
behaviors with their PCP. When adjusting for age, race, education, and annual income, patients who had an HIVpositive sex partner in the last 3 months were more likely
to have felt uncomfortable discussing their sexual behavior
with their PCP (OR: 5.46; 95% CI: 1.37–21.77, P = 0.02).
Of the 32 patients who asked their PCP for PrEP and were
not prescribed it, 29 reported reasons; some reasons were (1)
the PCP’s perception that prescribing PrEP is not a primary
care activity (52%), (2) the PCP was unaware of PrEP (21%),
and (3) the PCP did not feel comfortable prescribing PrEP
(10%). Furthermore, of the 34 patients who did not ask
their PCP for PrEP, 32 patients shared their reasons, which
included: (1) PrEP was initiated by an ID specialist (i.e., at
an inpatient or outpatient visit) for patients who were not seeking PrEP, but rather were offered PrEP, and they followed up
at the WUSTL ID specialty clinic (i.e., without engaging the
PCP) (31%), (2) they were uncomfortable discussing their
sexual behaviors with their PCP (22%), (3) they were uncomfortable revealing that they had an HIV-positive sex partner to
their PCP (19%), and (4) the perception that PrEP should be
obtained from an ID or HIV specialist (16%).
As a part of PrEP services at the ID clinic, those who had
indications for PrEP but did not have a PCP (n = 36), were uncomfortable with their PCP (n = 25), or who were comfortable
with but not prescribed PrEP by their PCP (n = 24) were referred to a new PCP. Overall, ID doctors referred 83% (85/
102) of PrEP seekers who sought care at the clinic to another

FIG. 2. Number of primary
care referrals made as part of
routine PrEP care at an academic infectious diseases
clinic.
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Table 4. Multivariable Regression Analysis
for Patients Who Felt Uncomfortable Discussing
Their Sexual Behaviors with Their Primary Care
Provider Before Seeking HIV Pre-Exposure
Prophylaxis Care at an Academic Infectious Diseases
Clinic, June 2014–February 2016 (N = 64)
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Variable

OR

Age (years)
18–24
1.0
25–34
0.73
>34
2.41
Race
White
1.0
Non-white
0.99
Education
Less than college 1.0
College graduate 0.58
Postgraduate
1.64
Annual income ($)
£12,000
1.0
12,001–24,000
0.51
24,001–36,000
0.57
>36,000
0.45
Having an HIV-positive sex
No
1.0
Yes
2.86*

95% CI

aORa

1.0
0.17–3.06 1.10
0.52–11.10 6.25

95% CI

0.15–8.02
0.59–65.98

0.32–3.03

1.0
0.59

0.13–2.62

0.15–2.26
0.44–6.11

1.0
0.77
6.12

0.14–4.18
0.79–47.11

1.0
0.09–3.11 0.16 0.01–2.01
0.13–2.57 0.47 0.07–3.30
0.12–1.76 0.05* 0.01–0.55
partner in the last 3 months
1.0
1.01–8.12 5.46* 1.37–21.77

a

Adjusted for age, race, education, annual income, and having an
HIV-positive sex partner.
*P £ 0.05.

PCP (Fig. 2). Patients were referred to a PCP who was able to
assess sexual risk in a culturally sensitive manner and who
was PrEP aware; this referral network had been developed
by the clinic. Thirty-two percent of the total referred patients
obtained a PCP within 12 months of their initial clinic date
(Fig. 2); of those without a PCP on intake, 36% (13/36)
obtained a PCP. There were 19 total PCPs located at 14 different healthcare centers: three providers at three federally qualified health centers (FQHC), one provider at a university
student health clinic, nine providers at seven private practices,
and six providers at three health systems-based clinics.
Of the 27 patients who obtained a PCP, 15% (4/27) selected a FQHC provider, 7% (2/27) a student health clinic
provider, and 78% (21/27) a private or health systemsbased PCP. Patients (n = 58) who did not obtain a PCP
reported the following reasons: (1) they did not follow-up
with the referral because they forgot, did not have time, or
wanted to get a PCP ‘‘later’’ (36%), (2) moved out of state
or discontinued PrEP before the 12-month time period of
analysis (28%), (3) felt comfortable with their established
PCP, did not want a new one, and wanted to receive PrEP
from a specialist (24%), (4) did not have options to obtain
a new PCP due to their insurance coverage (10%), and (5) became infected with HIV (2%).
Discussion

We documented that individuals seeking PrEP faced numerous barriers to obtaining PrEP from PCPs in metropolitan
Saint Louis, Missouri. Major barriers included not having a
PCP, having a PCP who was unaware of and/or perceived

PrEP to be a specialist’s responsibility, not knowing a PCP
could prescribe PrEP, and having a PCP but not feeling comfortable discussing sexual behaviors. Forty-eight percent of
these at-risk patients asked for PrEP from their PCPs, but
were not prescribed it, creating a large missed PrEPprescribing opportunity by PCPs. In the United States, widespread implementation of PrEP requires PCPs to be aware of
and willing to prescribe PrEP.
The study findings are consistent with previous studies and
suggest several potential approaches to improve PrEP delivery by PCPs.14,16,18–28 These include improved education
and training about sexual behaviors and PrEP, as well as interventions to address bias and stigma related to sexual behaviors.29 This study supports findings by Oldenburg et al.,
which revealed that structural stigma at the state level
leads to decreased use of PrEP for HIV prevention.30 Oldenburg et al. demonstrated that Missouri had a less supportive
social environment based on state-level structural stigma.30
We corroborate this study with our finding that 39% of individuals did not feel comfortable discussing their sexual behaviors with their PCPs, highlighting the importance of
combating this stigma on an individual provider–patient
level. The importance of eliciting sexual histories in culturally competent ways is increasingly recognized, and tools
are available to enhance primary provider cultural competence. Knowledge on how to initiate sexual behavior discussions will allow for adequate risk assessments and provide an
avenue to prescribe PrEP if indicated.31 Resources exist to
assist providers in developing comfortable settings for patients who identify as sexual or gender minorities or who
have HIV-positive sex partners.
As noted in other PrEP studies, we observed the ‘‘purview
paradox,’’ a term referring to the contradictory belief among
HIV specialists and PCPs about whose domain it is to be the
main PrEP prescriber.18 Many PCPs report perceiving that
PrEP was not a part of their expertise, and preferred to
refer PrEP patients to ID specialists.18 We observed that patients reported this reason when they asked for PrEP from
their PCPs, but also reported believing that PrEP was not
under the PCP’s prescribing jurisdiction. These challenges
might be best addressed by local provider training programs
and community awareness events about PrEP provision.
Our study also highlights the importance of access to care
and having a PCP. A third of patients who sought PrEP care
at our clinic had not engaged with a PCP in the last 12 months.
This study’s findings are consistent with national data showing
that 47% of Americans of all ages reported not visiting a PCP
in 2012.8 Referrals for PCPs within this study resulted in 32%
of patients obtaining a PCP with whom they could feel more
comfortable.
This study reports on the potential of a PrEP referral to be
the gateway for comprehensive primary and preventive care.
In this capacity, PrEP is an opportunity to link otherwise
healthy people to other services, including vaccinations
and mental health. In this study, ID and HIV specialists became the gateway to PrEP while also being the gateway to
primary care homes for a proportion of PrEP seekers. ID physicians and specialty clinics have the ability to play an important role in providing PrEP services, while also training PCPs
and garnering support from healthcare organization administrative leaders to establish a network of PrEP-prescribing
PCPs during initial local implementation as we had. We saw

MISSED PrEP OPPORTUNITY BY PCPS IN ST. LOUIS

an increase in several new PrEP-providing locations (three
FQHCs, a student health center, and several private sector
clinic locations) that were not previously providing PrEP,
as a result of our efforts to create a PCP referral network
for our patients.
Further studies are needed to evaluate how to successfully
link individuals prescribed PrEP to primary care services,
and to assess if these individuals are comfortable receiving
PrEP from their PCPs. Over 60% of patients who were referred
to a PCP did not follow through within 12 months. Understanding the gaps in the specialist-to-PCP PrEP care transition or the
desire not to have a PCP will help better incorporate PrEP into
broader preventive care on a population level.
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Limitations

Limitations to this study include a small sample size, patient self-reported reasons for not being prescribed PrEP,
and study conduction at a single academic institution,
which lessens generalizability. Although we did not categorize denial of prescription by the provider based on individual risk, we reported many characteristics regarding this
patient sample that demonstrated substantial risk for HIV
acquisition.
Conclusion

PrEP has the potential to curb HIV incidence in the United
States and PrEP implementation will need to be adapted for
each geographic and cultural context. PrEP holds the power
to engage individuals in comprehensive preventive healthcare who were not in routine care previously. However,
these early adopting PrEP users will need to have a comfortable environment in which to disclose their sexual behaviors
and to have supportive interactions with the healthcare system. Addressing these factors will help to establish the foundation for successful PrEP care retention in the region. Until
primary care organizations develop a large cadre of clinically
competent and culturally sensitive PrEP providers, ID specialists will need to assist in initial PrEP care provision
and to develop networks where PrEP seekers can transition
their care to the hands of PCPs, thereby fostering a sustainable PrEP implementation platform.
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